New Federal Program Expands Access to GLP-1 Weight-Loss Drugs for Medicare Patients @WPBSShortFlix
New Federal Program Expands Access to GLP-1 Weight-Loss Drugs for Medicare Patients  @WPBSShortFlix
Uploaded October 2026 | Updated November 2026, 1 day ago
Ozempic, Wegovy, Zepbound, various forms of the same type of medication, GLP-1s. Now, a new federal program is underway that's putting some GLP-1weight-loss drugs within reach for qualifying Medicare patients. We sat down with Kinney Drugs pharmacist Natalie Powers to learn more about the program, and some of the pros and cons of these popular weight-loss medications.

----
Funding for WPBS Weekly: Inside the Stories is provided by Carthage Savings and Loan and The Statewide Community Regrants Program, a regrant program of the New York State Council on the Arts with the support of the Office of the Governor and the New York State Legislature and administered by the St. Lawrence County Arts Council.
New Federal Program Expands Access to GLP-1 Weight-Loss Drugs for Medicare PatientsMeet More Whiz Quiz Competitors! 🧠🎉 Season 46 Premieres Tonight! 📺Inside Ironwood Sword School: The Art of Medieval Sword Martial ArtsTerry Talbot | What Does Community Service Mean to You?Secondhand Stories Chicken SanctuaryFrom Hockey Locker Rooms to Kingston’s Cookie ShopAnother Whiz Quiz Student Spotlight! 🎉 Playoffs Are Next!Early Spring Garden PrepPhilanthropist Deb MacSherry Supports People Affected by The AIDS EpidemicGetting Ready for Whiz Quiz! 🎉 Meet the StudentsThe Lowville Village Band Turns 200!Student Voices - Freedom & Opportunity | America @ 250
WPBS Digital Studios |

New Federal Program Expands Access to GLP-1 Weight-Loss Drugs for Medicare Patients

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER